Mycoplasma genitalium

Mycoplasma genitalium Overview

Mycoplasma genitalium is an emerging STI pathogen linked to urethritis, cervicitis, and pelvic inflammatory disease, with increasing antimicrobial resistance (Workowski et al., 2021). Its inclusion in STI panels supports diagnosis and guides targeted treatment when standard therapies fail.

References

Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park I., Reno, H., Jonathan M. Zenilman J.M.,Bolan, G. A. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187. https://doi.org/10.15585/mmwr.rr7004a1

Products used to detect Mycoplasma genitalium

STI PCR Panel – Large

The STI large PCR panel is designed for multiplex in vitro assessment of 9 common microbiota typically associated with transmission by sexual activity, using real-time PCR.

Women’s Health PCR Panel – Large

The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.